![β-D-Glucopyranuronic acid, 1-[2-[(2,3-dimethylphenyl)amino]benzoate]](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fcas-image%2Fthumb-webp%2F352889-b-d-glucopyranuronic-acid-1-2-23-dimethylphenyl-amino-benzoate.webp&w=3840&q=75)
CAS 102623-18-7: β-D-Glucopyranuronic acid, 1-[2-[(2,3-dimethylphenyl)amino]benzoate]
Formula:C21H23NO8
InChI:InChI=1S/C21H23NO8/c1-10-6-5-9-13(11(10)2)22-14-8-4-3-7-12(14)20(28)30-21-17(25)15(23)16(24)18(29-21)19(26)27/h3-9,15-18,21-25H,1-2H3,(H,26,27)/t15-,16-,17+,18-,21-/m0/s1
InChI key:InChIKey=DAHIGOGKMFBIOR-CURYNPBISA-N
SMILES:N(C1=C(C(O[C@@H]2O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]2O)=O)C=CC=C1)C3=C(C)C(C)=CC=C3
Synonyms:- 1-O-(2-(2,3-dimethylphenyl)aminobenzoyl)glucopyranuronic acid
- 1-O-{2-[(2,3-dimethylphenyl)amino]benzoyl}-beta-D-glucopyranuronic acid
- 1-[2-[(2,3-Dimethylphenyl)amino]benzoate] -D-Glucopyranuronic Acid
- 1-[2-[(2,3-Dimethylphenyl)amino]benzoate] b-D-Glucopyranuronic Acid
- Mefenamic Acid Glucuronide
- Mefenamic Acyl--D-glucuronide
- β-<span class="text-smallcaps">D</span>-Glucopyranuronic acid, 1-[2-[(2,3-dimethylphenyl)amino]benzoate]
- β-D-Glucopyranuronic acid, 1-[2-[(2,3-dimethylphenyl)amino]benzoate]
Sort by
Found 8 products.
Mefenamic-d3 Acyl-Beta-D-glucuronide
CAS:Controlled ProductApplications Labelled Mefenamic acid metabolite. References Besunder, J., et al.: Clin. Pharmacokinet., 14, 261 (1988), Smith, P., et al.: Drug Metab. Dipos., 18, 639 (1990), Kraus, D., et al.: Clin. Pharmacol. Ther., 54, 351 (1993), Sato, J., et al.: Biol. Pharm. Bull., 16, 811 (1993),Formula:C21H20D3NO8Color and Shape:NeatMolecular weight:420.43Mefenamic acid-acyl-b-D-glucuronide
CAS:Mefenamic acid-acyl-b-D-glucuronide is a synthetic drug that binds to albumin and human serum albumin. It has been shown to irreversibly inhibit human UDP-glucuronosyltransferase, an enzyme in the human liver that catalyzes the addition of glucuronic acid to drugs and other xenobiotics. Mefenamic acid-acyl-b-D-glucuronide has also been shown to inhibit the activity of a wide range of enzymes in humans, including isoenzyme UGT1A6, which is found in the liver and kidney. This drug has been studied as a potential treatment for pain and inflammation in humans.Formula:C21H23NO8Purity:Min. 95%Color and Shape:White To Off-White SolidMolecular weight:417.41 g/molβ-D-Glucopyranuronic acid, 1-[2-[(2,3-dimethylphenyl)amino]benzoate]
CAS:Formula:C21H23NO8Color and Shape:SolidMolecular weight:417.4092Mefenamic acid-acyl-β-D-glucuronide
CAS:Mefenamic acid-acyl-β-D-glucuronidePurity:95% minColor and Shape:Off-White Amorphous SolidMolecular weight:417.41g/molMefenamic Acyl-Beta-D-glucuronide
CAS:Controlled ProductStability Hygroscopic Applications Mefenamic acid metabolite. References Besunder, J., et al.: Clin. Pharmacokinet., 14, 261 (1988), Smith, P., et al.: Drug Metab. Dipos., 18, 639 (1990), Kraus, D., et al.: Clin. Pharmacol. Ther., 54, 351 (1993), Sato, J., et al.: Biol. Pharm. Bull., 16, 811 (1993),Formula:C21H23NO8Color and Shape:NeatMolecular weight:417.41
![β-D-Glucopyranuronic acid, 1-[2-[(2,3-dimethylphenyl)amino]benzoate]](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FIN%2Fthumb%2FDA0007YT.jpg&w=3840&q=75)
